Presently, over 160 innovative, software enabled systems are being used to efficiently manage and streamline various aspects of the complex supply chain of cell and advanced therapies
The USD 1.5 billion (by 2030) financial opportunity within the cell and advanced therapy supply chain management software solutions market has been analysed across the following segments:
Key Market Insights
- Presently, over 160 innovative, software-enabled systems are being used to efficiently manage and streamline various aspects of the complex supply chain of cell and advanced therapies
- Company involved in this domain are putting in significant efforts to develop advanced software solutions and also differentiate their offerings, from those of other industry players, in order to maintain a competitive edge
- North America is the major hub of innovation in this field, serving as the base for companies of all sizes, which are primarily engaged in developing cloud-based solutions for diverse applications
- The cell and advanced therapies market is characterized by an elaborate value chain, involving a multitude of processes and several stakeholders, each having a discrete set of priorities and requirements
- Increase in partnership activity reflects the growing interest of stakeholders in this industry; over 50% of reported deals were established to deploy software solutions for enhancing visibility and supply chain performance
- An analysis of recent activity on Twitter reveals the increasing interest and ongoing efforts of industry stakeholders in providing needle-to-needle traceability and supply chain orchestration solutions
- Given their cost saving potential across different processes and operations, we expect the cell and advanced therapy supply chain solutions market to grow at an annualized rate of around 25% over the next decade
- In the mid-long term, the projected opportunity is anticipated to be well distributed across various global regions, different end uses / applications and mode of deployment of various proprietary software solutions
Kwon more @ Cell and Advanced Therapies Supply Chain Management Market Size
Application area
- Sample collection and processing
- Manufacturing
- Logistics
- Patient identification and treatment follow-up
Type of software solution
- Cell orchestration platform
- Enterprise manufacturing system
- Inventory management system
- Laboratory information management system
- Logistics management system
- Patient management system
- Quality management system
Mode of Deployment
- Cloud-based solution
- On-premises solution
Scale of Operation
- Clinical
- Commercial
End user
- Biobank
- Cell therapy lab / commercial organization
- Hospital / medical center
- Research institute
Key geographical regions
- North America
- Europe
- Asia Pacific
- Rest of the world
Get Customized Report @ Cell and Advanced Therapies Supply Chain Management
key players
- Be The Match BioTherapies®
- Brooks Life Sciences
- Clarkston Consulting
- Cryoport
- Haemonetics
- Hypertrust Patient Data Care
- Lykan Bioscience
- MAK-SYSTEM
- MasterControl
- SAP
- SAVSU Technologies
- sedApta Group
- Stafa Cellular Therapy
- Title21 Health Solutions
- TraceLink
- TrakCel
- Vineti
Table of Contents
- Preface
- Executive Summary
- Introduction
- Current Market Landscape
- Company Competitiveness Analysis
- Cell and Advanced Therapies Supply Chain Management: Company Profiles
- Supply Chain Orchestration Platform: Emerging Trends and Key Players
- Funding and Investment Analysis
- Partnerships and Collaborations
- Supply Chain Utilization Use Cases
- Stakeholder Needs Analysis
- Cost Savings Analysis
- Market Forecast
- Executive Insights
- Concluding Remarks
- Appendix 1: List of Additional Supply Chain Management Software Solutions
- Appendix 2: Tabulated Data
- Appendix 3: List of Companies and Organizations
To purchase a copy, please visit https://www.rootsanalysis.com/reports/260/request-sample.html
Also Visit Our Latest Publication:
- Organ–based / Targeted Drug Delivery Devices Market for Biologics (Intra-organ / Intra-tumoral), 2020 - 2030
- Global Handheld Ultrasound Imaging Devices Market, 2020-2030
- Large Volume Wearable Injectors Market (5th Edition), 2020-2030: Focus on Bolus, Basal and Continuous Delivery Devices
- Medical Device CROs Market (2nd Edition), 2020 – 2030
About Roots Analysis
Roots Analysis is one of the fastest growing market research companies, sharing fresh and independent perspectives in the bio-pharmaceutical industry. The in-depth research, analysis and insights are driven by an experienced leadership team which has gained many years of significant experience in this sector.
Contact Information
Roots Analysis Private Limited
Gaurav Chaudhary
+1 (415) 800 3415
